Auqual Pharmaceuticals Private Limited

Auqual Pharmaceuticals Private Limited - trading in Faridabad, Haryana, India. Directors, charges & compliance details.
CIN U51900HR2021PTC097306 Incorporated 31 August 2021 ROC Haryana HQ Faridabad, Haryana, India
Active Private Limited Company trading MSME · Micro
Data last updated
Revenue · FY 2024
₹92.08 Lakh
▲ 192% YoY
Net profit · FY 2024
₹1.08 Lakh
Net margin 1.2%
EBITDA · FY 2024
₹1.46 Lakh
EBITDA margin 1.6%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
3
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Auqual Pharmaceuticals Private Limited

Data last updated:

Auqual Pharmaceuticals Private Limited is a private limited company based in Faridabad, Haryana, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 31 August 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U51900HR2021PTC097306.

The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Saurabh Khanduja and Ansul Khanduja.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 932 Vipul Plaza Sector – 81 Greater Faridabad, Haryana, India – 121002.

As per the financials filed for FY 2024, the company reported a revenue of ₹92.08 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.08 Lakh (net margin 1.2%) and EBITDA of ₹1.46 Lakh (EBITDA margin 1.6%).

Court records list 2 cases involving the company, including 2 filed by the company; 2 cases are pending.

Auqual Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-03-0040566).

Company details

CIN U51900HR2021PTC097306
Registration Number 097306
Incorporation Date 31 August 2021
ROC Haryana
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-HR-03-0040566

Recognitions & Rankings of Auqual Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-HR-03-0040566

Contact details

Auqual Pharmaceuticals Private Limited's registered office is in Faridabad, Haryana.

  • Registered Address
    C – 932 Vipul Plaza Sector – 81 Greater Faridabad, Haryana, India – 121002
  • Industry
    Trading, Specialty, Wholesale
Comprehensive company report
Auqual Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Auqual Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Auqual Pharmaceuticals Private Limited, buy the company report.

Financials of Auqual Pharmaceuticals Private Limited

FY 2025 filings available

Auqual Pharmaceuticals Private Limited reported revenue of ₹92.08 Lakh (up 192% YoY) for FY 2024.

Revenue · FY 2024
₹92.08 Lakh ▲ 192%
Net profit · FY 2024
₹1.08 Lakh margin 1.2%
EBITDA · FY 2024
₹1.46 Lakh margin 1.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 192%
EBITDA CAGR growth
1 year
▲ 133%

Revenue rose 192% in the latest year. EBITDA rose 133% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.46 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.08 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin1.6%
Net Profit Margin1.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Auqual Pharmaceuticals Private Limited, buy the company report.

Board of directors of Auqual Pharmaceuticals Private Limited

Auqual Pharmaceuticals has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Saurabh KhandujaDirector31 Aug 20215 Years 2 MonthsCurrent
Ansul KhandujaDirector31 Aug 20215 Years 2 MonthsCurrent
Honey RaniDirector31 Aug 20215 Years 2 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Auqual Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Auqual Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Auqual Pharmaceuticals Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Ansul Khanduja was appointed as Director on 31 Aug 2021.

AGM
Auqual Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Auqual Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana.
Appointed
Ansul Khanduja was appointed as Director.
Appointed
Honey Rani was appointed as Director.
Appointed
Saurabh Khanduja was appointed as Director.
Incorporation
31 Aug 2021
Auqual Pharmaceuticals Private Limited was registered on 31 Aug 2021 with Roc Haryana & aged 5 years 2 months as per MCA records.

Frequently asked questions

Auqual Pharmaceuticals is an active private limited company based in Faridabad, Haryana, India. The company works in specialty, within the trading industry. It was incorporated on 31 August 2021 (5+ years old) and is registered under CIN U51900HR2021PTC097306.

Auqual Pharmaceuticals has 3 current directors:

The latest financial statements of Auqual Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.

The CIN (Corporate Identification Number) of Auqual Pharmaceuticals is U51900HR2021PTC097306. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Auqual Pharmaceuticals has 2 court cases on record: 2 filed by the company. 2 are pending.

Auqual Pharmaceuticals was incorporated on 31 August 2021, making it 5+ years old. It is registered with the Registrar of Companies, Haryana.

Ansul Khanduja was appointed as Director on 31 Aug 2021. Honey Rani was appointed as Director on 31 Aug 2021. Saurabh Khanduja was appointed as Director on 31 Aug 2021.

Yes, Auqual Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-03-0040566).

The registered office of Auqual Pharmaceuticals is at C – 932 Vipul Plaza Sector – 81 Greater Faridabad, Haryana, India – 121002.

Auqual Pharmaceuticals operates in the trading industry, in the specialty segment.